🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the central 5-HT1B receptor occup...
Status
Completed
Location
Research Site
Start Date
2010-05
Trial ID
NCT01085123
Treatments Being Tested
The purpose of this study is to determine how useful and effective the use ...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00637286
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of telc...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-15
Trial ID
NCT00442936
The goal of this study is to measure medical resource utilization, treatmen...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01381523
Migraine is a chronic and sometimes progressive disorder, characterized by ...
Status
Completed
Location
Pamukkale University
Start Date
2016-01
Trial ID
NCT03145467
Treatments Being Tested
The purpose of this retrospective claims database study was to compare the ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01332500
Treatments Being Tested
This is a phase I study to evaluate the PBPK of zolmitriptan intranasal ver...
Status
Completed
Location
IMIM (Hospital del Mar Medical Research Institute)
Start Date
2023-07-12
Trial ID
NCT06074016
Treatments Being Tested
This study is the first study in humans with CVT-427 (zolmitriptan inhalati...
Status
Completed
Location
Site 001
Start Date
2015-11
Trial ID
NCT02609945
Treatments Being Tested
The purpose is to evaluate the effectiveness and safety profile of zolmitri...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01-01
Trial ID
NCT03377257
Treatments Being Tested
Cocaine potently inhibits the reuptake of serotonin (5-HT). Increased synap...
Status
Completed
Location
University of Kentucky
Start Date
2021-10-15
Trial ID
NCT05019430
Treatments Being Tested